[{"address1": "5005 McConnell Avenue", "city": "Los Angeles", "state": "CA", "zip": "90066", "country": "United States", "phone": "310 665 2928", "fax": "310 665 2963", "website": "https://www.armatapharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Los Angeles, California. Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc.", "fullTimeEmployees": 66, "companyOfficers": [{"maxAge": 1, "name": "Dr. Deborah L. Birx M.D.", "age": 66, "title": "CEO & Director", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 536431, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mina  Pastagia M.D., MS", "age": 48, "title": "Chief Medical Officer", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 463754, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  House", "title": "Senior VP of Finance & Principal Financial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter  Hubbard", "title": "Vice President of Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Pierre  Kyme Ph.D.", "title": "Chief Business Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "irWebsite": "http://ir.ampliphibio.com/phoenix.zhtml?c=84981&p=irol-stockquote", "maxAge": 86400, "priceHint": 4, "previousClose": 2.17, "open": 2.11, "dayLow": 2.19, "dayHigh": 2.1978, "regularMarketPreviousClose": 2.17, "regularMarketOpen": 2.11, "regularMarketDayLow": 2.19, "regularMarketDayHigh": 2.1978, "beta": 0.805, "forwardPE": -1.3949045, "volume": 1874, "regularMarketVolume": 1874, "averageVolume": 7350, "averageVolume10days": 5010, "averageDailyVolume10Day": 5010, "bid": 2.0, "ask": 3.25, "bidSize": 1200, "askSize": 800, "marketCap": 79240992, "fiftyTwoWeekLow": 1.98, "fiftyTwoWeekHigh": 4.48, "priceToSalesTrailing12Months": 21.30707, "fiftyDayAverage": 2.321, "twoHundredDayAverage": 2.73375, "currency": "USD", "enterpriseValue": 216705616, "floatShares": 11035112, "sharesOutstanding": 36183100, "sharesShort": 4540, "sharesShortPriorMonth": 3372, "sharesShortPreviousMonthDate": 1727654400, "dateShortInterest": 1730332800, "sharesPercentSharesOut": 0.0001, "heldPercentInsiders": 0.70248, "heldPercentInstitutions": 0.03824, "shortRatio": 0.86, "shortPercentOfFloat": 0.0004, "impliedSharesOutstanding": 36183100, "bookValue": -0.888, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -67043000, "trailingEps": -1.15, "forwardEps": -1.57, "lastSplitFactor": "1:14", "lastSplitDate": 1557446400, "enterpriseToRevenue": 58.27, "enterpriseToEbitda": -5.297, "52WeekChange": -0.15444016, "SandP52WeekChange": 0.31754446, "exchange": "ASE", "quoteType": "EQUITY", "symbol": "ARMP", "underlyingSymbol": "ARMP", "shortName": "Armata Pharmaceuticals, Inc.", "longName": "Armata Pharmaceuticals, Inc.", "firstTradeDateEpochUtc": 769440600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "e9006f47-0d3e-3b07-8861-14c121fcb2a4", "messageBoardId": "finmb_84546611", "gmtOffSetMilliseconds": -18000000, "currentPrice": 2.19, "targetHighPrice": 7.0, "targetLowPrice": 7.0, "targetMeanPrice": 7.0, "targetMedianPrice": 7.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 26405000, "totalCashPerShare": 0.73, "ebitda": -40911000, "totalDebt": 146140000, "quickRatio": 0.224, "currentRatio": 0.251, "totalRevenue": 3719000, "revenuePerShare": 0.103, "returnOnAssets": -0.25090998, "freeCashflow": -31061124, "operatingCashflow": -38554000, "operatingMargins": -11.30869, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-12-07"}]